These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5688651)

  • 21. Incorporation of radioactivity from labeled serotonin and tryptamine into acid-insoluble material from subcellular fractions of brain. I. The nature of the substrate.
    Alivisatos SG; Ungar F
    Biochemistry; 1968 Jan; 7(1):285-92. PubMed ID: 5312358
    [No Abstract]   [Full Text] [Related]  

  • 22. Tryptamine receptors: fact, myth or misunderstanding?
    Greenshaw AJ; Dewhurst WG
    Brain Res Bull; 1987 Feb; 18(2):253-6. PubMed ID: 3032375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug antagonism and reversibility of the binding of indoleamines in brain.
    Ungar F; Hitri A; Alivisatos SG
    Eur J Pharmacol; 1976 Mar; 36(1):115-25. PubMed ID: 1063074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical characterization of [3H]tryptamine binding sites from rat brain.
    Brüning G; Rommelspacher H
    Biochem Int; 1989 Jan; 18(1):227-33. PubMed ID: 2541722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain.
    Kaulen P; Brüning G; Rommelspacher H; Baumgarten HG
    Brain Res; 1986 Feb; 366(1-2):72-88. PubMed ID: 3697697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.
    Perry DC
    J Pharmacol Exp Ther; 1986 Feb; 236(2):548-59. PubMed ID: 3003349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.
    Martin LL; Roland DM; Neale RF; Wood PL
    Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for uptake into serotoninergic neurones.
    Ross SB; Ask AL
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):270-7. PubMed ID: 7368945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the responses of cortical neurones to iontophoretically applied tryptamine and 5-hydroxytryptamine in the rat.
    Jones RS
    Neuropharmacology; 1982 Mar; 21(3):209-14. PubMed ID: 7070598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The subcellular distribution of endogenous and exogenous serotonin in brain tissue: comparison of synaptosomes storing serotonin, norepinephrine, and gamma-aminobutyric acid.
    Kuhar MJ; Shaskan EG; Snyder SH
    J Neurochem; 1971 Mar; 18(3):333-43. PubMed ID: 5559247
    [No Abstract]   [Full Text] [Related]  

  • 31. The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1970 Nov; 40(3):582P-583P. PubMed ID: 5497834
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines.
    Cerletti A; Taeschler M; Weidmann H
    Adv Pharmacol (1962); 1968; 6(Pt B):233-46. PubMed ID: 5658327
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro.
    Saavedra JM; Axelrod J
    Science; 1972 Mar; 175(4028):1365-6. PubMed ID: 5059565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine oxidase in mammalian blood platelets.
    Paasonen MK; Solatunturi E
    Ann Med Exp Biol Fenn; 1965; 43(2):98-100. PubMed ID: 4378456
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin.
    Fishman JB; Rubins JB; Chen JC; Dickey BF; Volicer L
    J Neurochem; 1991 Jun; 56(6):1851-4. PubMed ID: 1902871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.
    Agúndez JA; Gallardo L; Martínez C; Gervasini G; Benítez J
    Pharmacogenetics; 1998 Jun; 8(3):251-8. PubMed ID: 9682270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Receptor affinity of ecliptic fixed tryptamine and serotonin analogs].
    Rehse K; Peetsch R; Kehr W
    Arch Pharm (Weinheim); 1987 Oct; 320(10):1072-83. PubMed ID: 3435231
    [No Abstract]   [Full Text] [Related]  

  • 38. Tryptamine binding sites: potential site of action of tetrahydro-beta-carbolines.
    Kellar KJ; Cascio CS
    Prog Clin Biol Res; 1982; 90():209-12. PubMed ID: 7111320
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine, and norepinephrine.
    Meek JL; Krall AR; Lipton MA
    J Neurochem; 1970 Dec; 17(12):1627-35. PubMed ID: 5492984
    [No Abstract]   [Full Text] [Related]  

  • 40. Relative selectivity of some conformationally constrained tryptamine analogs at 5-HT1, 5-HT1A and 5-HT2 recognition sites.
    Taylor EW; Nikam S; Weck B; Martin A; Nelson D
    Life Sci; 1987 Oct; 41(16):1961-9. PubMed ID: 3657392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.